Rimonabant
PRADO
Sanofi · Phase 3 · Terminated · Enrollment 2666
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Rimonabant
Sanofi · Phase 3 · Terminated · Enrollment 2666
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| 2 | Obesity or overweight | n/r | n/r | n/r | n/r |